ORF_ID	CONTIG	START	STOP	ORIENTATION	CUT_OFF	PASS_EVALUE	Best_Hit_evalue	Best_Hit_ARO	Best_Identities	ARO	ARO_name	Model_type	SNP	Best_Hit_ARO_category	ARO_category	PASS_bitscore	Best_Hit_bitscore	bit_score	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	LABEL	ID	Model_id
BGC0000820.1|Physostigmine_1	ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.681	0	1007	+	Loose	n/a	0.714051	Erm(30)	32.43	ARO:3001265, ARO:3000950, ARO:3000910, ARO:3001050, ARO:3000859, ARO:3001373, ARO:3001302, ARO:3001374, ARO:3001035, ARO:3000620, ARO:3000944	TEM-190, TEM-182, TEM-185, TEM-169, rmtA, TEM-40, TEM-78, chrB, Erm(30), adeL, TEM-83	protein homolog model	n/a	antibiotic target modifying enzyme; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance	antibiotic inactivation enzyme; antibiotic target modifying enzyme; determinant of aminoglycoside resistance; determinant of beta-lactam resistance; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance; efflux pump complex or subunit conferring antibiotic resistance; gene involved in self-resistance to antibiotic; protein(s) and two-component regulatory system modulating antibiotic efflux	500	27.7202	27.7202, 25.0238, 24.6386, 24.2534, 23.8682, 25.0238, 25.0238, 23.8682, 24.2534, 24.2534, 24.2534	ATGGCCGCAAGTGCAACGCGTCGCCTTTATGAGAGTTTCCCTTTTCCTTCGCCGGGAGCCGACCGGCCGCTGATTGACGTCGTCGGAAACGAGCTGCCCCTGGTGGTCGAAGGCGGGCTGCGTGACGGATGGTCAGTGCTCGACGCGGGGTGCGGCACCGGGCACACCCTGATCGGTCTGGCCCGCGCGTATCCCCACGTGCACTTTGTGGGGCTCGAACCGTCCGACGCCTCACGCGACATCGCACGGCATCTGGCCGAGCGGCACGGCACCACGAATGTGGAAATCGTCGACGGCGCAATTCCGGACACCGTAATCGAGCGCCGTTTTGAATTCATCTACAGCTACGGTGTCGTCCACCACCTGCCAGATCCGCAGGCAGGGCTCAATTGGCTTGGCGACCACCTGGCCGAGGACGGATTACTGCATGTGTGGCTGTACAACGCCATCGGTGAGGCTCAGCGCATGCGTGACCGCGAACTGGTCCGGTTGATGGCCGCGCATGCGGACGGCCATGGACTCGACGTCGTCAGGGCTCTCGGGTTCTCCCTGTCGCTCGACGCCTACGGTATGCCCGGGGCCTGGGCCGGCACCGCGCTGGACCAGGCGGAACAGGACGTCTTCGACGCGGACGCCTACCTCAATCCCGTGGTGCACACCCTGCGGTTCGGTGACCTCCCGGAGCTGCTGGACGGAGTGACCGACTGGGTGGCCGCCGATCGCGTCTACGGGCCGCACGGCGCGCCCTACCTCGACCTGAGCGGCACCGGCGGGTTTCCCGCGCAGGGGCCCGAGCTGCTGCGCCCCGAAGACCTCTTCGACGACCCCGGGCTGCGGACCCGGATCGGCGACCTCGGCAATCTCGATCGTCTACGGGCGGTGGAACTCGTCCTGCGGCCCACCGGCTTCCGCGCACTGGCCGGACGGGGCGGTTCCCTGAACCGGTGTTCCCGGCGCATCGCCGGCAATCTCCTGACCGGACCCGCCGGCCGGGCCCAGGTCCCCTGA	MAASATRRLYESFPFPSPGADRPLIDVVGNELPLVVEGGLRDGWSVLDAGCGTGHTLIGLARAYPHVHFVGLEPSDASRDIARHLAERHGTTNVEIVDGAIPDTVIERRFEFIYSYGVVHHLPDPQAGLNWLGDHLAEDGLLHVWLYNAIGEAQRMRDRELVRLMAAHADGHGLDVVRALGFSLSLDAYGMPGAWAGTALDQAEQDVFDADAYLNPVVHTLRFGDLPELLDGVTDWVAADRVYGPHGAPYLDLSGTGGFPAQGPELLRPEDLFDDPGLRTRIGDLGNLDRLRAVELVLRPTGFRALAGRGGSLNRCSRRIAGNLLTGPAGRAQVP	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	BGC0000820.1|Physostigmine_1#1#1008#1#ID=1_1;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.681	gnl|BL_ORD_ID|161|hsp_num:0	1224
BGC0000820.1|Physostigmine_7	ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.710	5863	7068	+	Loose	n/a	5.66736	SMB-1 beta-lactamase	30.77	ARO:3000854, ARO:3001404	OXA-9, SMB-1 beta-lactamase	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of beta-lactam resistance	antibiotic inactivation enzyme; determinant of beta-lactam resistance	500	25.0238	25.0238, 24.6386	ATGACCACTCCGACTGAGCGCGCGGAGCGTGCAGTTGACACCTGGCTCCAACGCATCCGCAAAGGCCCACCCGGACCGTTCCCGCACCGGCTGGTCACCCGCGCCGTGCAGGCCCACGGCAGCACGGCGCTGCCCGAGCGCCTGAGAGGGCAGCTCATCGATGCCTGGGACTGGTCCCGCAGCTGCTCCCTCGAACCCGGCAGCGAGGAGTGGGCGACCGCTGCCTGGCTGGAGTGCCTGACCAGTTCCCTGCGCAACGCTCCCTCCTACGGCGCGTACACGATGACCTCGCTGTTCGGCCGGTGGAGCCGCCTGGGCGACTTCCCCCGGCGCAACGCACAACTGTCCGCGCTGCTCACCGCCGACCTGATCCGGTACGAACTACGGCGTGCCACCCACGAGGACCACCTCGGCGAACGCCGCTCCCGCAGCACGGCCGCCACCCTCCTCGCCCGCCATCTGGACGAGGACCGCGGCTGGGCCGAAACCACCTGCCGACCCAAACCCGAGGGGGGCTCGCAGGCCATACAGCGCTGCAACCATCTGCTGTCCGCCGGCGGCCGGGGACTACCCGCTCCCCTCGCACTGTTGGTGGAGTCGTCACTTCCGGTGGCGACGACGGAGCCGGACGAGCCCCTGTTCATCCGCTCCGTACAGATCATGGAACTCCTCGCCGAGCAGGCCGCGTTCCACCTCGGCGAGGCACACCGGCGGGCCCGCGCCGCCACCCCGGAGCCGTCCTCGCTGGCCATGCTGCTGCATGCCACCGCCGACAGTCTGGACCGCGCCCAACACGTCTTCCGCCTGGTGTCCACCATCGATCCCACCCAGTTCGCCGCCATCCGCGCGGCCACCGCGGGCACGGGCGCGTTGCAGTCAACGGGCTTCGCCCGACTGGAGCGCTGCTGCCGTGGTGAGGCCGGGCTGCGCCCGGAGACCGTTGCCGCCGTCGGGCTGGTGACAGCCCCGACCCCCGCCCCCTCCCTGTCCACCACACTCGCGCGGGTCACCACCCGGCTGGAGACACACGACCCGACCGCGGCCGGACACTTACGCCTGGCCATCCAGGCAGTGAACGCACAGTGGCAACGGTGGAAGCGCACCCACCTCGGTGTCGCGAAGAAGATCATCGGCGATGTGCCGGGCACCGGCGGAACGGACGGTGTGCGCTACCTCGCCCGTCACCTTGAGGAGCCACTCCTGTGA	MTTPTERAERAVDTWLQRIRKGPPGPFPHRLVTRAVQAHGSTALPERLRGQLIDAWDWSRSCSLEPGSEEWATAAWLECLTSSLRNAPSYGAYTMTSLFGRWSRLGDFPRRNAQLSALLTADLIRYELRRATHEDHLGERRSRSTAATLLARHLDEDRGWAETTCRPKPEGGSQAIQRCNHLLSAGGRGLPAPLALLVESSLPVATTEPDEPLFIRSVQIMELLAEQAAFHLGEAHRRARAATPEPSSLAMLLHATADSLDRAQHVFRLVSTIDPTQFAAIRAATAGTGALQSTGFARLERCCRGEAGLRPETVAAVGLVTAPTPAPSLSTTLARVTTRLETHDPTAAGHLRLAIQAVNAQWQRWKRTHLGVAKKIIGDVPGTGGTDGVRYLARHLEEPLL	MKIIASLILAAFASVAQAQDRDWSSPQQPFTIYGNTHYVGTGGISAVLLSSPQGHILVDGTTEKGAQVVAANIRAMGFKLSDVKYILSTHSHEDHAGGISAMQKLTGATVLAGAANVDTLRTGVSPKSDPQFGSLSNFPGSAKVRAVADGELVKLGPLAVKAHATPGHTEGGITWTWQSCEQGKCKDVVFADSLTAVSADSYRFSDHPEVVASLRGSFEAVEKLSCDIAIAAHPEVNDMWTRQQRAAKEGNSAYVDNGACRAIAAAGRKRLETRLASEKR	BGC0000820.1|Physostigmine_7#5864#7069#1#ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.710	gnl|BL_ORD_ID|1068|hsp_num:0	753
BGC0000820.1|Physostigmine_8	ID=1_8;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.704	7065	8546	+	Loose	n/a	2.17247	patB	40.62	ARO:3000025	patB	protein homolog model	n/a	efflux pump complex or subunit conferring antibiotic resistance	efflux pump complex or subunit conferring antibiotic resistance	770	26.5646	26.5646	GTGAAGCCCGCTGAGGCGAAACCGCCCCACATGGACCACGACACCTTCCGCTCCCTGGGCCACCAGGCGATCGACTGGATCGCCGACTACTGGCAGCATCTGGCGGACCGGCCCGTCGCCCCCTTGGTCGAACCCGGCACCGTCCGCGCCCAGCTGCCGACGACCCCGCCCGAATACGGCGAGGACTTTCCCGCGCTCCTCTCCGACCTCGAACGGATCGTGCTGCCGGGCCTGCTGCACTGGCAACACCCCCGCTTCTTCGGCTACTTCCCCGCGAACGCCTCCGGCCCCGCCGTCCTGGCCGAGCTGTTGTCAGCGGGCCTGGGCGTCCAGGGGATGAACTGGAACACCAGCCCGGCCTGCACCGAGGTCGAGCAGCAGATGCTGGACTGGTTCGTGCACCTGCTCGGCCTGCCCGAGCACTTCCGTGGCGGAGGGGTCATCCAGGACACCGCCTCCAGCGCCGTCCTGGTGGCGCTGCTCACCGCCCTGCACCGGGCCAGCGCGGGCCGCACCCGCGACCACGGCACCGGCGAGTGCGGCTACCGGGTCTACCTGACCGCCGAGACGCACTCGGCGGCCCGCAAGGCCGCCGTCATCACCGGACTGGGCCTGCGCGCCGTGTGCGAGGTGGCCACCGACGCCGACGGCGCCATGGACGCAGCCGACCTGGCAGCCCGCATCCAGGCCGACCTCGCCGCCGGCCTGACCCCGCTGATGGTCGTGGCCACCCGCGGTACCACCTCTGATCTCTCCTTCGATCCCCTGGAGGACATCGGCCCCGTCTGCCGCCGGCACGGCGTGTGGCTCCACGTCGACGCCGCGTACGCCGGTGTGGCCGCGGTCTGCGACGAACTGCACTGGGTCAACGACGGCGTGCGCTACGCGGACTCGTACTGCACCAACCCGCACAAGTGGCTGCTGACCAACTTCGACTGCGACCTGCTGTGGGTGGCCGACCCCGAAGCCCTCGTCAACGCCCTGAGCGTGCTCCCCGCATACCTGCGCAACCCGGCCTCCGAATCGGGCCGGGTCACCGACTACCGCCACTGGCAGGTCCCACTGGGCCGCCGCTTCCGCGCACTGAAACTGTGGTCCGTGCTCCGCTGGTACGGCGCCGAGGGCCTCCGCTCCCACATCCGCACCGGCGTACGCCACGCCCGACTCTTCGCAGACCTGGTCCGCGAAGACGACCGCTTCACCCTGCTCGCCCCGGCCACCCTGGGCCTGGTGACGTTCCGTCACGCAGGATCCGACACGGACAACCGAAACCTCCTGCATGCCATCAACGCCGAGGGAACCACCTTCCTCACCCACTCCGAGAAGAACGGGACCTTCTTCCTCCGCTTCGCCACCGGGGGCACGCACACGGAGGACCACCATGTTCACGAAGCATGGCGCGCCGTCCAGAACGCCGTCCAGAACGCCGTCCCACGCGCTCAACACGCCACCGACGGCACGGCTGACGCGCTGAACGGGTAG	VKPAEAKPPHMDHDTFRSLGHQAIDWIADYWQHLADRPVAPLVEPGTVRAQLPTTPPEYGEDFPALLSDLERIVLPGLLHWQHPRFFGYFPANASGPAVLAELLSAGLGVQGMNWNTSPACTEVEQQMLDWFVHLLGLPEHFRGGGVIQDTASSAVLVALLTALHRASAGRTRDHGTGECGYRVYLTAETHSAARKAAVITGLGLRAVCEVATDADGAMDAADLAARIQADLAAGLTPLMVVATRGTTSDLSFDPLEDIGPVCRRHGVWLHVDAAYAGVAAVCDELHWVNDGVRYADSYCTNPHKWLLTNFDCDLLWVADPEALVNALSVLPAYLRNPASESGRVTDYRHWQVPLGRRFRALKLWSVLRWYGAEGLRSHIRTGVRHARLFADLVREDDRFTLLAPATLGLVTFRHAGSDTDNRNLLHAINAEGTTFLTHSEKNGTFFLRFATGGTHTEDHHVHEAWRAVQNAVQNAVPRAQHATDGTADALNG	MGKYDFTSLPNRLGHHTYKWKETETDSEVLPAWIADMDFVVLPEIHQAVQTYADQLVYGYTYASEDLIKEVQKWEATQYGYNFDKEALVFIEGVVPAISTAIQTFTKEGEAVLINTPVYPPFARSVKLNNRRLITNSLVEKDSLFEIDFDQLEKDLVEEEVKLYVLCNPHNPGGRVWEKEVLEKIGQLCQKHGVLLVSDEIHQDLTLFGHKHQSFNTINPAFKNFAIVLSSATKTFNIAGTKNSYAVIENPKLRLAFQKRLLANNQHEISGLGYLATEAAYRYGKDWLEELKQVFEDHINYVVDLFGKETKIKVMKPQGTYLIWLDFSAYDLTDETLQELLRNEAKVILNRGLDFGEEGSLHARINIAMPKSLLQEVCQRIVATFAKC	BGC0000820.1|Physostigmine_8#7066#8547#1#ID=1_8;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.704	gnl|BL_ORD_ID|1869|hsp_num:0	2112
BGC0000820.1|Physostigmine_4	ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.700	2860	3663	+	Loose	n/a	0.543401	Erm(30)	50.0	ARO:3001265, ARO:3002657, ARO:3001304, ARO:3000600, ARO:3000347, ARO:3000522, ARO:3000593, ARO:3000598, ARO:3000392, ARO:3000326, ARO:3001303, ARO:3000838, ARO:3000596, ARO:3000495, ARO:3001521, ARO:3000592, ARO:3000375	Erm(34), ErmN, ErmO, arlR, ErmB, OXA-333, ErmA, ErmG, APH(6)-Ia, ErmE, ErmX, Erm(37), ErmD, Erm(30), Erm(31), ErmS, ErmQ	protein homolog model	n/a	antibiotic target modifying enzyme; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance	antibiotic inactivation enzyme; antibiotic target modifying enzyme; determinant of aminoglycoside resistance; determinant of beta-lactam resistance; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance; efflux pump complex or subunit conferring antibiotic resistance; protein(s) and two-component regulatory system modulating antibiotic efflux	400	27.335	27.335, 26.9498, 26.5646, 25.409, 26.5646, 24.6386, 25.409, 26.5646, 28.1054, 26.1794, 26.1794, 24.2534, 27.335, 25.0238, 23.483, 25.7942, 23.8682	ATGATGCAGGGACAGCCGCACCAGGATGCGGGCATGCCCGAGCCGTACGCCGCGACCGCCGACGTGTACGACCGGCTCGTCGACTACGCCATCGCCGAGTGGGGAGAGTGCCCCCGGCCGCAGATGGCCGACTTCGTCGAGCAGGCATGGGCGGCTCGCGGGCACCGCGTGCGCCGGGTGCTCGAACTGTGCTGCGGCACCGGGCTGATGACCGAGCAACTGGTCCGGCGCGGTTACGAGGTCACCGCCGTCGACCGTTCCGAGACCATGCTGGCCCTGGCGAAGCAGCGGGTGGGCGGTGCGGCCGACTTCCATCAGATCGAACTGCCCGCCCCGCTGCCCGACGGTGCGGATGCCGTGGTGTGCACCGCGGCCGCCTTCAACTACCAGGCCAGCGCCCGATCTCTGGGAGAGACCCTGCGCGCCGTGGCCACGGTGCTGCCGGCGGGTGCGACGTTCGTCTTCGACATCGAGACCGCCGCACTCCTCAAGGGACACTGGGGCAACCGCGTGTGGGCCGCCGACGAGGGCGATCTGGCGTTCATCTGGGACTTCACGAGTGAGCCGGACACCACCTACTGCGATGTGCACTACACCCAGTTCACCCGCCACGAGGCGGGAGCGGACGCCTACACCGGCGTCCGCGAGGTGCACCGGCTGTACGCCTTCGACCACGACACCGTCCGCGCCCAGGCGCGTGCCGCCGGATTCGCGCAGGCGGAGGTGTTCGACAACTACACCGAGCGCCCCGCCACCGACACCACCCGCTATGAGACCTGGGTACTCACCCGAGACGAGCGCTGA	MMQGQPHQDAGMPEPYAATADVYDRLVDYAIAEWGECPRPQMADFVEQAWAARGHRVRRVLELCCGTGLMTEQLVRRGYEVTAVDRSETMLALAKQRVGGAADFHQIELPAPLPDGADAVVCTAAAFNYQASARSLGETLRAVATVLPAGATFVFDIETAALLKGHWGNRVWAADEGDLAFIWDFTSEPDTTYCDVHYTQFTRHEAGADAYTGVREVHRLYAFDHDTVRAQARAAGFAQAEVFDNYTERPATDTTRYETWVLTRDER	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	BGC0000820.1|Physostigmine_4#2861#3664#1#ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.700	gnl|BL_ORD_ID|161|hsp_num:0	1224
BGC0000820.1|Physostigmine_3	ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.692	2059	2844	+	Loose	n/a	0.033159	Erm(37)	25.44	ARO:3000392, ARO:3001306, ARO:3004102, ARO:3002668, ARO:3003727, ARO:3002667	kamB, rmtG, rmtD, Erm(37), vanKI, ErmW	protein homolog model	n/a	antibiotic target modifying enzyme; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of streptogramin resistance	antibiotic resistance gene cluster, cassette, or operon; antibiotic target modifying enzyme; determinant of aminoglycoside resistance; determinant of lincosamide resistance; determinant of macrolide resistance; determinant of resistance to glycopeptide antibiotics; determinant of streptogramin resistance; protein(s) conferring antibiotic resistance via molecular bypass	450	30.8018	30.8018, 27.7202, 24.6386, 25.0238, 23.8682, 27.335	ATGGCAGACGACGCGCACGCCCCGATGTACGGGGCCATCGCTGAGATCTACGACCGACTGGATGACTGGATCGTCGCCACCTGGCACGAGCAGCCGGTCCCCGAACGGGTGGCCTTCCTGCGCAAGCGGTGGGAGCAGCGCGACGGCGAGGTGCGGGACGTGCTGGACCTGTGCTGCGGCACCGGCAGCGTGCTGCATGAGCTCAAAGGGGCCGGCTATGAGGTCACCGGGCTCGACCAGTCCCCGCAGATGCTCGGCCTCGCCCGGCAGCGCCTCGGTGACGGAACCGCACTGATCCAGGCGCAACTGCCCGACATCCCGGTGCCCGACGCCGCCATGGACGCGGTGTGTTCCACCGGCGCGGCGCTGAGCTACACCCCCGGTGAGGCAGCGCTGGCCCAGATCCTCCTGGCCGTGCACCGCGTCCTGCGCCCCGGCGGCGTCTTCGTGTTCGACGTCCTGTCCCGCCACATGATCACCGAACACGCGGGCCGGCACGTATGGGCCGCCGATCAGGGCGACTTCGCCTTCATCTGGGAGTTCACCAACCCCAGCGAGAAGTACAGCGAAGCCTTCTACACGCAGTTCCTCCGGGAGGGCGGACCGGATTCCGCCAGGTACGTACGCACCAGCGAGAAGCATCGCCTGTACGTCCTCGACCACTCCCCGGTGCGGCGCGCCGCCGAGCGGGCCGGCTTCACCACCGCAGAGGTGCTCGACAACTACACCGACACCCCCGCCCACGAGAGCACGCTCTACGACACGTGGGTCCTGACCCGCGCCTGA	MADDAHAPMYGAIAEIYDRLDDWIVATWHEQPVPERVAFLRKRWEQRDGEVRDVLDLCCGTGSVLHELKGAGYEVTGLDQSPQMLGLARQRLGDGTALIQAQLPDIPVPDAAMDAVCSTGAALSYTPGEAALAQILLAVHRVLRPGGVFVFDVLSRHMITEHAGRHVWAADQGDFAFIWEFTNPSEKYSEAFYTQFLREGGPDSARYVRTSEKHRLYVLDHSPVRRAAERAGFTTAEVLDNYTDTPAHESTLYDTWVLTRA	MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAVELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLVAADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR	BGC0000820.1|Physostigmine_3#2060#2845#1#ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.692	gnl|BL_ORD_ID|2064|hsp_num:0	468
BGC0000820.1|Physostigmine_6	ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	5331	5879	+	Loose	n/a	1.01423	AAC(6')-Iaj	45.45	ARO:3003677, ARO:3002600, ARO:3002580, ARO:3003676, ARO:3002586, ARO:3002578, ARO:3002596, ARO:3002548, ARO:3002592, ARO:3002585, ARO:3002599, ARO:3002598, ARO:3002559, ARO:3002576, ARO:3002579, ARO:3002591, ARO:3002595, ARO:3002577, ARO:3002594, ARO:3002581, ARO:3002546, ARO:3002582	AAC(6')-Iaj, AAC(6')-Ib10, AAC(6')-Ib11, ANT(3'')-Ii-AAC(6')-IId fusion protein, AAC(6')-Ib', AAC(6')-Ib8, AAC(6')-Ib9, AAC(6')-IIa, AAC(6')-IIc, AAC(6')-IIb, AAC(6')-IId, AAC(6')-Ib3, AAC(3)-Ib/AAC(6')-Ib'', AAC(6')-32, AAC(6')-31, AAC(6')-Ib-Hangzhou, AAC(6')-30/AAC(6')-Ib' fusion protein, AAC(6')-Ib4, AAC(6')-Ib7, AAC(6')-Ib-Suzhou, AAC(6')-Ib, AAC(6')-Ip	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of aminoglycoside resistance	antibiotic inactivation enzyme; determinant of aminoglycoside resistance	275	25.7942	25.7942, 26.9498, 26.1794, 26.1794, 23.8682, 25.409, 25.7942, 26.1794, 26.1794, 33.4982, 26.1794, 26.5646, 24.6386, 26.1794, 26.1794, 26.1794, 28.4906, 26.1794, 23.483, 26.1794, 26.9498, 26.1794	ATGAACACCTTCCGGACCGCGACGGCACGCGACATCCCCGATGTCGCCGCCACCCTCACCGAAGCCTTCGCCACTGACCCACCGACCCAATGGGTCTTCCCGGACGGCACCGCGGCGGTCTCCCGCTTCTTCACCCACGTCGCCGACCGCGTCCACACAGCAGGCGGGATCGTCGAACTCCTGCCCGACAGAGCCGCGATGATCGCCCTGCCCCCGCACGTACGACTGCCCGGCGAAGCAGCCGACGGCAGACAGGCCGAGATCCAGCGCCGGCTGGCCGACCGCCACCCGCTCACCCCGCACTACTACCTCCTGTTCTACGGCGTGCGCACGGCCCACCAGGGCTCAGGGCTGGGCGGGCGGATGCTCGCCCGACTCACCTCCCGGGCCGACCGCGACCGCGTGGGCACCTACACCGAGGCCAGCACCTGGCGCGGCGCCCGCCTGATGTTGCGTCACGGCTTCCACGCCACGCGGCCGCTGCGGCTTCCCGACGGGCCGTCCATGTTCCCCCTCTGGAGAGACCCGATCCATGACCACTCCGACTGA	MNTFRTATARDIPDVAATLTEAFATDPPTQWVFPDGTAAVSRFFTHVADRVHTAGGIVELLPDRAAMIALPPHVRLPGEAADGRQAEIQRRLADRHPLTPHYYLLFYGVRTAHQGSGLGGRMLARLTSRADRDRVGTYTEASTWRGARLMLRHGFHATRPLRLPDGPSMFPLWRDPIHDHSD	MEYSIINIVEQNNYQIDAARILTNTFLDIGNKTWPTIQSAIDEVEECIDLPNICIGLIHNNQLIGWVGLRPMYDKTWELHPLVVRTDYQSKGIGSVLLAEVEKRAREVGIIGIILGTDDEYNKTSLSEITIDENNIFDAIQNIKNIHNHPYEFYQKNGYMIVGIIPNANGLRKPDIWMWKSLLN	BGC0000820.1|Physostigmine_6#5332#5880#1#ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	gnl|BL_ORD_ID|356|hsp_num:0	2191
BGC0000820.1|Physostigmine_2	ID=1_2;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.725	1096	2025	+	Loose	n/a	1.80457	BahA	20.95	ARO:3003984, ARO:3001771, ARO:3001772, ARO:3001770, ARO:3001769	OXA-57, BahA, OXA-42, OXA-43, OXA-59	protein homolog model	n/a	determinant of resistance to peptide antibiotics	antibiotic inactivation enzyme; determinant of beta-lactam resistance; determinant of resistance to peptide antibiotics	500	26.1794	26.1794, 25.7942, 26.1794, 26.1794, 26.1794	GTGCTCGAACCCCGCATCAAAGAACGCTTCCTCGACGGTCTCAACACGGCCCCGCCGTTGGAAGGGACGACTCCCGACGCCTTGCGCGGAGCGGTTGAGGAACTGCTCTCCTTCTGCGCGCCGCCTCTCCCCGTCGCCCAGGTCATGGACGGCACGACCACGGAAGCCACGGGGGCAGTGCCGTTCCGGGTCTACCATCCGCGGCCGGGGGTCCCCCTCCCGCTGGTCGTGTACTTCCACGGCGGCGGCTGGATGGCCGGCAGCATCGCGTTCATGGATCCTCCGCTGCGCGCCCTGGCGGTCGAGGCCGGCGTGGTGGTGCTGAGCGCGGAGTACCGGCTCGCGCCGGAGCATCCCTTCCCGGCCGGGCTGCACGACGCGCAGGCCGTCACCTCCTGGGCCTACGAGAACGCCGCCGCGCTCGGGGCCGACCCCGAGCGGTTCGCGGTCGCCGGGGACAGTGCGGGCGCGGCTCTCGCCGTCGTCGTCGCACTTGAGGCCCGTGGCTCGGCCGTCTCCATCGGCCACCAGCTCCTGATCAATCCGGCCGTCGACCCGCGGATGAACACCGCCTCCTACCGGGAGTTCGCGACGGGCTACCAGAACAGCGCGTCGATGATGAACCTGTGCTGGCGCACGTACCTGAACCGGCCCGACGGGCCCCTGGACGACGCGCCCTGGCAGGCCGCCCCGGTCTTCGCCCCGGACCTCTCCGGCCTGCCGCCGACCACCGTCATCACGGTCGAGTACGACCCGCTGCGCGACGAGGGCGAGGCATACGCCGCGCGGATGGCCGCCGCCGGGGTGCCGACCACGCTGGTGCGCTGCCCGGGTCTCATCCACTGCTCACTCCACCTGGACGGCGTAGCCCCTCACGCCGCCTCCCTACGGCAGCACGCGGTGCGGGCGCTGACCACCGCGTTCGCCTGA	VLEPRIKERFLDGLNTAPPLEGTTPDALRGAVEELLSFCAPPLPVAQVMDGTTTEATGAVPFRVYHPRPGVPLPLVVYFHGGGWMAGSIAFMDPPLRALAVEAGVVVLSAEYRLAPEHPFPAGLHDAQAVTSWAYENAAALGADPERFAVAGDSAGAALAVVVALEARGSAVSIGHQLLINPAVDPRMNTASYREFATGYQNSASMMNLCWRTYLNRPDGPLDDAPWQAAPVFAPDLSGLPPTTVITVEYDPLRDEGEAYAARMAAAGVPTTLVRCPGLIHCSLHLDGVAPHAASLRQHAVRALTTAFA	MEIHKEKEKEKGVTFFRRIMANRKRRGPLSPGWKGASLGLGATGFILILIQANYLLTGHGVGKFIVGTFLFLFAAALISGLASMLLHGVKKLPSRYIWMLLYSLIMFLFCFIVQPGVSAVFIVSLAIVLSLFGALAYKFAAGSYKQVSKTRKIGAMACLSLITIAIGAGSFWLIRAGDDAAPDITLKQLKTSTRYEDSTMNNPAEQGTYPVQSLLYGSPDNYRTEFNQSGSLTTQTVDASRFVEKWSSLRTKSLGFGPEAMPLNGRVWYPEGEGTFPLVLIVHGNHLMNDYSDPGYEYLGRLLASKGYIFVSVDENFLNFSPYEDLFLISPLLSENPARGLLLLEHLQTWKDWNSDPDNPFYQKVDMERIALIGHSRGGEAVAIAAAYNKLGRHPDHGDIKFDYNFSIRSLISIAGTDGQYKPQGKPLPLQDVNYLSLHGAHDMDVNSLDGAKQYHRIRYTKGTNYMKSLVYIYGANHGQFNGGWGRGDGAGLGNQLFNLRQIMPRDEQETIAKVFISSFLDATLKDQRQYREVFKDLGYAKEWIPDNLYVGNYYDSQTTLIADFHEDIDLQSTTLPGGSLRGENLQQWKEEKVKTKWGEADYSAVRLGWNSNGSSEPASYTVTLPDNGVETGRDSSIVFSLADARKTEESGDPKELINFTITVEDRKGHQASLPLSHISKLPPVIEGKLLKWPFSNAGNTSEPVFQSYDFQLDDYYKMNPDFNPQQLSKIRIEFNLTKRGSILLRDVGIRS	BGC0000820.1|Physostigmine_2#1097#2026#1#ID=1_2;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.725	gnl|BL_ORD_ID|849|hsp_num:0	2521
BGC0000820.1|Physostigmine_5	ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.710	3667	5334	+	Loose	n/a	0.798256	ANT(3'')-Ii-AAC(6')-IId fusion protein	30.65	ARO:3002598, ARO:3002548, ARO:3002577, ARO:3002576, ARO:3002592, ARO:3002600, ARO:3002581, ARO:3002546, ARO:3002580, ARO:3002591, ARO:3003676, ARO:3002579, ARO:3002547, ARO:3003772, ARO:3002582, ARO:3002578, ARO:3002594, ARO:3002596, ARO:3002599	AAC(3)-Ib/AAC(6')-Ib'', AAC(6')-Ib', AAC(6')-Ib-Suzhou, AAC(6')-Ib-Hangzhou, AAC(6')-Ib-cr, ANT(3'')-Ii-AAC(6')-IId fusion protein, AAC(6')-Ib, AAC(6')-30/AAC(6')-Ib' fusion protein, Brucella suis mprF, AAC(6')-Ib7, AAC(6')-IIa, AAC(6')-Ib8, AAC(6')-Ib9, AAC(6')-Ib4, AAC(6')-IIc, AAC(6')-Ib11, AAC(6')-IId, AAC(6')-Ib10, AAC(6')-Ib3	protein homolog model	n/a	antibiotic inactivation enzyme; determinant of aminoglycoside resistance	antibiotic inactivation enzyme; antibiotic target modifying enzyme; determinant of aminoglycoside resistance; determinant of fluoroquinolone resistance; determinant of resistance to peptide antibiotics; gene altering cell wall charge	600	28.4906	28.4906, 29.261, 28.8758, 28.1054, 29.261, 27.335, 28.1054, 28.8758, 29.261, 28.1054, 29.261, 29.261, 28.1054, 25.7942, 28.8758, 28.1054, 27.335, 25.409, 28.4906	ATGCTGATCTGCGGACTGAAACTCACCCACGACGGTGGCCTGGCCGTGGTGGAAGACGGCAGGCTGTTGTTCTCCGTGGAAATGGAGAAGCTGGACAACAACCGGCGATTCCAACCGCTGGACCGGCTGGAGCTCGCGGAGGACGTCCTCGCCCGGGAAGGCGTCACGATCGGCGACATCGACCGGTTCGTGGTGGACGGCTGGTTCGCCCCGCTGGGCCAGAACCAGCAGCACCCGGCGCTGCACGTGACCCACCACGGGCGGCCGGTCACGCTGCCCGTCGCCCCCTACCAGGACCAGCCCGGCACGGACGTCCTGACCCGATACACCTTCGACGGCCTTCCGCTCGGCTCCGCCACGTACCCCTACAGCAGCTACCACCACAGCACCCAGCACCTGATGGGCGCCTACGCCACCAGCCCCTTCGCCCAGCGCGGACAGGACGCGCTGGTACTGGTGTGGGACGGCGGCATGACGCCCGTCCTGTACCGGGTGCAGCCCGAACCCCTCCACGTGACACGCCTGGGCGAGCTGTTCCCCCTGTACGGCAGCGTCTTCGCGGACTTCTGCGCCGCCCTTCCGCCGTTTCGCAGCGCCACCACGCCGGCCACGCCCGACCCGCACCTCATGCCCCGCAACCTGGACGTGGCAGGCAAGGCCATGGCGTACGCCGCGCTCGGCACGGACGACCCGGGCTTCGACGGCGTCTTCGCGGCGCACCTCGACGGAAGGGACCTGTCCTTCACCATGGGCGACGACCTCGCCCGCGCCCTCGCCGAAGGCGACAGTCCCCCGTGGCCGGACGCCACGGACGCCGACCTCGTCGCCAGCTTCCAGGGCTATCTGGGCCGCCGACTGCACACCGCCCTCAGCGTCGCCCTGCGCGACGGCGGCCTGCCGCGCCGCCTGTGCCTGGCCGGCGGCTGCGCACTGAACATCAAATGGAACAACCGGCTGCGCTCCTCCGGACAGTTCGAGCAGGTATGGGTGCCGCCGTTCCCCAACGACTCCGGGGCCGCCCTGGGGGCCGCCGCCGTGGAGTGGTCACGGACCGGCGGGCCGGCCGTCCTGGACTGGTCCGTGTACCGGGGCCCCCGGCTCCGGCCCGCGGAGGGCGATCCGCCGGGCTGGACCTCCACCCCCTGCGACATCGAGGGACTGGCGCGCTTCCTCCACGACAGTGAACGGCCCGTCGTCGTCCTCACCGGACGAGCGGAACTGGGGCCACGAGCCCTGGGGCACCGCAGCATCTTCGCGTCGGCCACCGACCCCGGCATGAAAGAGCACCTCAACCGCATCAAGGACCGCGAGAACTACCGGCCCGTCGCCCCGGTGTGCCTGGAACACCGGGCCCCGGAGCTGTTCTCCCCGGGCACCCCCGACCCCCACATGCTCTTCGACCACGACACCCGCGTCGGCTGGGAAGCCAAGGTCCCCGCCGTCGTACACCTGGACGGCACCGCACGTCTGCAGACCGTCAACGACCGGGAGGCGCCCTTCGTCCACACGCTGCTGATCGCCTACGAGAAGCTGTCGGGCATCCCGCTGCTCTGCAACACCAGCGCCAACCACAAAGGCCGCGGTTTCTTCCCGGACGTCGCGTCGGCCGCGGCCTGGGGACGCGTACCGGCCATCTGGTCCGAAGGCCGCCTCTACCGCCGCGCATGA	MLICGLKLTHDGGLAVVEDGRLLFSVEMEKLDNNRRFQPLDRLELAEDVLAREGVTIGDIDRFVVDGWFAPLGQNQQHPALHVTHHGRPVTLPVAPYQDQPGTDVLTRYTFDGLPLGSATYPYSSYHHSTQHLMGAYATSPFAQRGQDALVLVWDGGMTPVLYRVQPEPLHVTRLGELFPLYGSVFADFCAALPPFRSATTPATPDPHLMPRNLDVAGKAMAYAALGTDDPGFDGVFAAHLDGRDLSFTMGDDLARALAEGDSPPWPDATDADLVASFQGYLGRRLHTALSVALRDGGLPRRLCLAGGCALNIKWNNRLRSSGQFEQVWVPPFPNDSGAALGAAAVEWSRTGGPAVLDWSVYRGPRLRPAEGDPPGWTSTPCDIEGLARFLHDSERPVVVLTGRAELGPRALGHRSIFASATDPGMKEHLNRIKDRENYRPVAPVCLEHRAPELFSPGTPDPHMLFDHDTRVGWEAKVPAVVHLDGTARLQTVNDREAPFVHTLLIAYEKLSGIPLLCNTSANHKGRGFFPDVASAAAWGRVPAIWSEGRLYRRA	MSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLKPYSDIDLLVTVAAQLDETVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQRKDILAGIFEPATTDVDLAILLTKVRQHSLALAGSAAEDFFNPVPEGDLFKALSDTLKLWNSQPDWEGDERNVVLTLSRIWYSAATGKIAPKDIVANWAIERLPDQHKPVLLEARQAYLGRGEDCLASRADQLAAFVHFVKHEATKLLGAMPVMSKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	BGC0000820.1|Physostigmine_5#3668#5335#1#ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.710	gnl|BL_ORD_ID|1805|hsp_num:0	339
